7-OH vs. Traditional Kratom in 2026: The Updated Difference
7-OH products and traditional kratom are not interchangeable categories. Traditional kratom is botanical Mitragyna speciosa material with a broad alkaloid profile led by mitragynine. Products built around concentrated 7-hydroxymitragynine, or 7-OH, contain that single alkaloid at levels above the trace amounts associated with natural leaf. In July 2026, federal agencies put a proposed numerical threshold behind that distinction.
This article updates our original guide to 7-hydroxymitragynine vs. traditional kratom. The central comparison still holds, but the regulatory details have changed. Here is what the current federal record says, what it does not say, and how to verify the product in front of you.
Regulatory status reviewed July 21, 2026. Federal, state, and local rules can change. Check current requirements before buying, selling, or carrying any kratom-related product.
The Short Answer: The Measured 7-OH Level Matters
7-OH is a named alkaloid, not a synonym for kratom. Federal records describe it as a minor or trace constituent in botanical kratom. The same records distinguish that natural background level from products that isolate, synthesize, add, or otherwise concentrate 7-OH.
That makes the front label only the beginning of the review. A product called “kratom,” “extract,” or “botanical” can still carry a concentrated 7-OH number. The meaningful evidence is the labeled amount, the total contents of the article or container, and a batch-specific certificate of analysis.
What Changed Since the Original Comparison
When Tusk published the original comparison, the core issue was product identity: broad-spectrum botanical material on one side and concentrated 7-OH on the other. Since then, FDA, HHS, and DEA have taken coordinated steps aimed specifically at above-threshold 7-OH products.
FDA Focused Federal Action on Concentrated 7-OH
On July 29, 2025, FDA announced warning letters to firms marketing concentrated 7-OH products. Its accompanying scientific assessment said enhanced products contain 7-OH far above the levels found in natural botanical material. FDA also stated that 7-OH is not an approved drug and is not authorized as a food additive.
The warning letters moved the issue from general agency concern to named product enforcement. They also reinforced the need for accurate product identity, batch records, and labels that state the compound rather than hiding it behind a general botanical description.
DEA Proposed a Temporary Schedule I Threshold
On July 6, 2026, DEA published a notice of intent to temporarily place 7-OH above a specified threshold in Schedule I. As of this article’s July 21 review date, DEA had published the notice, not the temporary scheduling order itself. That distinction matters because a proposed or announced action is not the same as an effective order.
DEA’s notice also says the action is not intended as a blanket scheduling of natural kratom. Instead, it defines a concentration and amount threshold designed to separate botanical material from above-threshold 7-OH articles. Readers should recheck the Federal Register before relying on this status because DEA said it could issue the temporary order after the statutory notice period.
HHS Proposed a Matching Food Threshold
HHS published a separate proposed rule for foods and dietary supplements on the same date. Its proposed threshold matches the DEA framework and its public-comment period was scheduled through July 31, 2026. Together, the notices show a coordinated focus on measured 7-OH content rather than the word “kratom” alone.
The July 2026 Federal Threshold in Plain English
DEA’s proposed line has two parts. For botanical Mitragyna speciosa material, the notice covers material containing more than 0.050% 7-OH by dry weight. For synthetic or further-processed alternative articles, the notice covers material containing more than 0.050% 7-OH or more than 1.00 milligram of 7-OH in the article.
That second test means percentage is not the only number to inspect. The amount in the full tablet, gummy, strip, bottle, or other article can matter even when a percentage looks small. A label that presents only a ratio or a vague “alkaloid blend” does not give you enough information to apply the federal framework.
The chemical name does not reveal how the material was produced. DEA states that naturally occurring and synthetic 7-OH have the same chemical structure. The product-level distinction therefore comes from the concentration, total amount, processing history, and supporting documentation, not from a different spelling of the molecule.
7-OH vs. Traditional Kratom: A Practical Comparison
| Point of comparison | Traditional botanical kratom | Concentrated 7-OH product |
|---|---|---|
| Base material | Leaf-derived botanical material from Mitragyna speciosa | Isolated, synthesized, added, or further-processed 7-OH material |
| Alkaloid profile | Broad profile led by mitragynine, with 7-OH at a minor or trace level | 7-OH presented as a headline compound or concentrated beyond botanical background levels |
| Numbers that matter | Batch MIT and 7-OH results, plus contaminant screening | 7-OH concentration and total amount, plus contaminant screening |
| July 2026 federal posture | DEA says its proposed action is not intended to schedule natural kratom as a whole | DEA notice targets 7-OH above the proposed 0.050% or 1.00 mg thresholds |
| Verification standard | Current, batch-matched label and COA | Current, batch-matched label and COA with clear 7-OH concentration and total amount |
The difference is measurable. It should be documented through measured concentration and batch-specific lab results. If those details are missing, the buyer is being asked to trust branding instead of evidence.
How to Read the Label and COA
A clean review starts with product identity, then moves to the batch. Use this five-point check:
- Find the exact product format. Confirm whether the item is leaf powder, a capsule, an extract, a tablet, a gummy, a liquid, or another processed form.
- Locate the 7-OH number. Look for both percentage and milligrams. If the label lists a per-unit amount, also confirm the unit count in the full package.
- Match the batch. The lot or batch code on the package should correspond to the code on the laboratory report.
- Check the method and laboratory. The report should identify an independent lab and a quantitative analytical method, not just display a vendor-designed badge.
- Review the full panel. Alkaloid identity is one part of verification. Heavy metals and microbial screening belong in the same quality review.
For a line-by-line walkthrough, use Tusk’s guide to reading a kratom COA. You can also see why third-party testing matters when the marketing claim and the measured result need to be separated.
Why MIT Transparency Still Matters
The 7-OH conversation can make buyers ignore the rest of the alkaloid profile. That is a mistake. Traditional kratom is led by mitragynine, represented by the abbreviation MIT, and a complete label should display that benchmark clearly.
Our guide to what MIT means on a kratom label explains the primary number. A complete COA shows why a botanical profile cannot be reduced to one headline compound. Together, the MIT result and the supporting panel provide context that a 7-OH-only label leaves out.
Tusk’s buyer standard is direct: read the label, match the batch, and verify the numbers. A marketing adjective cannot replace measured alkaloid content. A current COA is the mechanism that ties a specific package to a specific result.
Frequently Asked Questions
No. 7-OH is one alkaloid associated with Mitragyna speciosa. Traditional kratom contains a broader alkaloid profile led by mitragynine, while products marketed around concentrated 7-OH center the label and content on that single compound.
As of July 21, 2026, DEA had published a notice of intent to temporarily schedule 7-OH above a specified threshold, but the temporary scheduling order was not yet published. FDA had separately taken enforcement action against products it identified as illegal 7-OH products. Rules in every applicable jurisdiction should be checked before any transaction.
Federal scientific records describe 7-OH as a minor or trace constituent in botanical kratom. The regulatory focus is on products that contain it above the proposed threshold through isolation, synthesis, addition, or further processing.
DEA’s July 2026 notice proposes more than 0.050% 7-OH by dry weight for botanical kratom. For synthetic or further-processed alternative articles, it proposes more than 0.050% or more than 1.00 milligram of 7-OH in the article.
Read the percentage and milligram statements on the label, then match the package lot number to a current certificate of analysis from an independent laboratory. The report should identify the tested batch and show a quantitative 7-OH result.
Verify the Batch Before You Choose the Format
The updated 7-OH discussion is not about finding a stronger adjective. It is about knowing what the product is, how much of the named alkaloid it contains, and whether the batch documentation supports the label.
Start with Tusk’s Certificate of Analysis search and verify the results yourself. If you are comparing concentrated botanical formats, review the label and batch documents for the Tusk extract capsule category before making a selection. Read the label. Match the batch. Verify the numbers.